JNPMEDI

Incheon, South Korea Founded: 2020 • Age: 6 yrs
Cloud-based clinical trial data management solutions are provided.

About JNPMEDI

JNPMEDI is a company based in Incheon (South Korea) founded in 2020.. JNPMEDI has raised $10.3 million across 1 funding round from investors including Aju IB Investment, Kakao Ventures and Gentium Partners. JNPMEDI offers products and services including Maven Clinical Cloud, Maven CDMS, Maven eCOA, and Professional Services. JNPMEDI operates in a competitive market with competitors including Lokavant, eClinical Solutions, Datacubed, SolveBio and IgniteData, among others.

  • Headquarter Incheon, South Korea
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Jnpmedi Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.3 M (USD)

    in 1 rounds

  • Latest Funding Round
    $10.3 M (USD), Series A

    Nov 21, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of JNPMEDI

JNPMEDI offers a comprehensive portfolio of products and services, including Maven Clinical Cloud, Maven CDMS, Maven eCOA, and Professional Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

End-to-end solution for clinical trial operations and data management.

Tool for collecting and managing clinical trial data efficiently.

Platform for electronic clinical outcome assessments in trials.

On-demand support for life science business strategies and development.

People of JNPMEDI
Headcount 50-200
Employee Profiles 5
Employee Profiles
People
Kwunho Jeong
Chief Executive Officer
People
Jay Lee
Chief Of Staff

Unlock access to complete

Funding Insights of JNPMEDI

JNPMEDI has successfully raised a total of $10.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.3 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $10.3M
  • First Round

    (21 Nov 2022)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2022 Amount Series A - JNPMEDI Valuation Pavilion Capital Partners
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in JNPMEDI

JNPMEDI has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Aju IB Investment, Kakao Ventures and Gentium Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital investments are directed toward IT startups.
Founded Year Domain Location
Diversified investment, VC & financial advisory firm
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by JNPMEDI

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - JNPMEDI

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jnpmedi Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of JNPMEDI

JNPMEDI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lokavant, eClinical Solutions, Datacubed, SolveBio and IgniteData, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of clinical data analytics and trial management platform for CRO
domain founded_year HQ Location
Cloud-based software solutions for clinical data management are provided.
domain founded_year HQ Location
Provider of solutions for patient engagement and data management in clinical trails
domain founded_year HQ Location
Genomic data analytics platform is provided for precision medicine.
domain founded_year HQ Location
Patient data is transformed for clinical trials via archer technology.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Jnpmedi

Frequently Asked Questions about JNPMEDI

When was JNPMEDI founded?

JNPMEDI was founded in 2020 and raised its 1st funding round 2 years after it was founded.

Where is JNPMEDI located?

JNPMEDI is headquartered in Incheon, South Korea.

Who is the current CEO of JNPMEDI?

Kwunho Jeong is the current CEO of JNPMEDI.

Is JNPMEDI a funded company?

JNPMEDI is a funded company, having raised a total of $10.3M across 1 funding round to date. The company's 1st funding round was a Series A of $10.3M, raised on Nov 21, 2022.

What does JNPMEDI do?

JNPMEDI was founded in 2020 in Incheon, South Korea, as a provider of cloud-based clinical trial data management solutions. A SaaS platform is utilized to deliver digitalization services across pharmaceuticals, biotechnology, digital medicines, and digital medical devices. Operations focus on streamlining data handling for these sectors, with services tailored to support research and development processes in the healthcare industry.

Who are the top competitors of JNPMEDI?

JNPMEDI's top competitors include Lokavant, eClinical Solutions and IgniteData.

What products or services does JNPMEDI offer?

JNPMEDI offers Maven Clinical Cloud, Maven CDMS, Maven eCOA, and Professional Services.

Who are JNPMEDI's investors?

JNPMEDI has 5 investors. Key investors include Aju IB Investment, Kakao Ventures, Gentium Partners, Pavilion Capital Partners, and Murex Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available